DE1447746U - - Google Patents

Info

Publication number
DE1447746U
DE1447746U DENDAT1447746D DE1447746DU DE1447746U DE 1447746 U DE1447746 U DE 1447746U DE NDAT1447746 D DENDAT1447746 D DE NDAT1447746D DE 1447746D U DE1447746D U DE 1447746DU DE 1447746 U DE1447746 U DE 1447746U
Authority
DE
Germany
Prior art keywords
dor
dio
der
oinor
uin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DENDAT1447746D
Other languages
German (de)
English (en)
Publication of DE1447746U publication Critical patent/DE1447746U/de
Active legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DENDAT1447746D Active DE1447746U (OSRAM)

Publications (1)

Publication Number Publication Date
DE1447746U true DE1447746U (OSRAM)

Family

ID=755735

Family Applications (1)

Application Number Title Priority Date Filing Date
DENDAT1447746D Active DE1447746U (OSRAM)

Country Status (1)

Country Link
DE (1) DE1447746U (OSRAM)

Similar Documents

Publication Publication Date Title
Frost et al. Raman spectroscopy of the sampleite group of minerals
DE1447746U (OSRAM)
Ardern The oxidation of sewage without the aid of filters. Part II
Castella et al. Pattern of malignant lymphoma in the United Arab Emirates-a histopathologic and immunologic study in 208 native patients
HUANG Cervical primary Ewing's sarcoma in intradural and extramedullary location and skip metastasis to cauda equina
Denning et al. Neuralgic amyotrophy due to parvovirus infection
FORESI et al. Calcareous plankton high resolution biostratigraphy (foraminifera and nannofossils) of the uppermost langhian–lower serravallianras il-pellegrin section (MALTA)
WO2020132844A1 (zh) 炎性相关疾病防治的小rna药物及其组合
Chua et al. Taeniasis and neurocysticercosis among Malaysians.
Paybast et al. Watch out for neuromyelitis optica spectrum disorder onset or clinical relapse after COVID-19 vaccination: What neurologists need to know?
Broijl et al. Phase I dose escalation of LAVA-051, a novel bispecific γδ-T cell engager (Gammabody™), in relapsed/refractory hematological malignancies
Fehmi et al. CIDP and nephrotic syndrome: A shared immune mechanism through anti-Contactin 1 antibodies?
Maslennikov et al. Ecological and toxicological assessment of hazard, posed by water contamination of water bodies with polyvinyl nitrate
Monet et al. Crowned dens syndrome diagnosed on 18F-FDG PET/CT
Eidner et al. Clinical manifestation of POEMS syndrome with features of connective tissue disease
Rohmayanti et al. Post Herpetic neuralgia
Kwok et al. 2677 Cerebellar dysfunction post COVID infection
Koh et al. Syphilitic spinal disease: an old nemesis revisited. a case series and review of literature
Zeyen et al. High-dose MTX-based polychemotherapy for primary CNS lymphoma in younger patients: Long-term efficacy of the modified Bonn protocol
EP3959203A1 (en) 3-hydroxy-2-phenyl-6-(pyrazol-4-ylmethyl)pyridine derivatives as pde4d inhibitors
Ariatti et al. Cutting the edge of idiopathic recurrent orbital myositis
Kawakami et al. Orbital inflammatory lesion as an initial manifestation of systemic nasal type NK/T-cell lymphoma
Melani et al. Immunotherapy of Lymphomatoid Granulomatosis
Boes et al. High-grade B-cell NHL of the brachial plexus followed by infiltration of the spinal cord.
So et al. Central Nervous System Neoplasms in Acquired Immunodeficiency Syndrome